Sign In

Antiretroviral Therapy.

HIV Question Bank

Antiretroviral Medications and Initial TherapyQuestion 7/10

Questions in Topic

A 24-year-old transgender woman is seen in clinic for an initial HIV evaluation and to start antiretroviral therapy. The plan is to start a regimen consisting of dolutegravir plus tenofovir alafenamide-emtricitabine. Her baseline laboratory studies obtained 5 days prior, at the time of her initial HIV diagnosis, show a CD4 count of 220 cells/mm3 and an HIV RNA level of 46,520 copies/mL. An HIV drug resistance genotype is pending.

After initiating antiretroviral therapy, which one of the following approaches is recommended as the most important aspect of monitoring the patient's initial response to antiretroviral therapy?

Prev  Skip

Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Question Last Updated
July 25th, 2024

Steps to Acquire CE for this Question Bank Topic:

1

Answer

Answer all questions
2

Score 80%+

Answer correctly
3

Claim CE

Choose CNE or CME
4

Give Feedback

Complete survey
5

Print Certificate

Obtain proof of CE

This question requires improvement because:


Comment further on how to improve this question or summary:



Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.